{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:28:04Z","timestamp":1783628884686,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.bcmd.2014.11.006","type":"journal-article","created":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T19:48:36Z","timestamp":1416858516000},"page":"258-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["IL-6, IL-10, c-Jun and STAT3 expression in B-CLL"],"prefix":"10.1016","volume":"54","author":[{"given":"Halina","family":"Antosz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Wojciechowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Sajewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Choroszy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Marzec-Kotarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Osiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Paj\u0105k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Tomczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Jargie\u0142\u0142o-Baszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Baszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2014.11.006_bb0005","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0010","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1172\/JCI23409","article-title":"In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells","volume":"115","author":"Messmer","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature06246","article-title":"Recognition of microorganisms and activation of the immune response","volume":"449","author":"Medzhitov","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0020","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1046\/j.1365-2141.2002.03759.x","article-title":"Defective assembly of the B-cell receptor chains accounts for its low expression in B-chronic lymphocytic leukaemia","volume":"118","author":"Payelle-Brogard","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0025","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1182\/blood-2004-09-3643","article-title":"Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the mu and CD79a chains","volume":"105","author":"Vuillier","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0030","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1073\/pnas.090087097","article-title":"Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells","volume":"97","author":"Gordon","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0035","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2141.2009.07849.x","article-title":"Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia","volume":"147","author":"Anderson","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0045","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.semcancer.2010.09.004","article-title":"Antigens in chronic lymphocytic leukemia\u2014implications for cell origin and leukemogenesis","volume":"20","author":"Rosen","year":"2010","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0055","doi-asserted-by":"crossref","first-page":"e788","DOI":"10.1371\/journal.pone.0000788","article-title":"A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins","volume":"2","author":"N\u00fa\u00f1ez Miguel","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0060","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.it.2009.07.009","article-title":"Endotoxin tolerance. New mechanisms, molecules and clinical significance","volume":"30","author":"Biswas","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0065","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0070","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1172\/JCI40008","article-title":"Conventional DCs reduce liver ischemia\/reperfusion injury in mice via IL-10 secretion","volume":"120","author":"Bamboat","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0075","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.immuni.2006.02.014","article-title":"IFN-\u03b3 suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB\/AP-1 proteins","volume":"24","author":"Hu","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0080","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0085","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","article-title":"The JAK\u2013STAT signaling pathway: input and output integration","volume":"178","author":"Murray","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1152\/ajpcell.00026.2003","article-title":"Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages","volume":"285","author":"Okugawa","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccr.2009.01.009","article-title":"Inflammation and cancer: IL-6 and STAT3 complete the link","volume":"15","author":"Bromberg","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccr.2007.12.020","article-title":"Autocrine IL-6 signaling: a key event in tumorigenesis?","volume":"13","author":"Grivennikov","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0105","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bcp.2006.07.008","article-title":"Suppression of IL-1beta expression by the Jak 2 inhibitor AG490 in cerulein-stimulated pancreatic acinar cells","volume":"72","author":"Yu","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc1275","article-title":"The STATs of cancer\u2014new molecular targets come of age","volume":"4","author":"Yu","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jcp.10364","article-title":"STAT proteins: from normal control of cellular events to tumori genesis","volume":"197","author":"Calo","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0120","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1038\/sj.onc.1203594","article-title":"IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled","volume":"19","author":"Raddy","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0125","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1038\/sj.onc.1203481","article-title":"Serine phosphorylation of STATs","volume":"19","author":"Decker","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/10428190009089430","article-title":"Gab-family adapter molecules in signal transduction of cytokine and growth factor receptors, and T and B cell antigen receptors","volume":"37","author":"Hibi","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0135","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0140","first-page":"87","article-title":"Inhibition of c-Jun N-terminal kinase by SP600125: a cDNA microarray analysis","volume":"7","author":"Champelovier","year":"2010","journal-title":"CANCER GENOMICS PROTEOMICS"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0145","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.4049\/jimmunol.172.12.7703","article-title":"Stat3 activation in acute lung injury","volume":"172","author":"Gao","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0150","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nm0605-595","article-title":"Validating Stat3 in cancer therapy","volume":"11","author":"Darnell","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0155","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1158\/0008-5472.CAN-05-2203","article-title":"Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3","volume":"66","author":"Leslie","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0160","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4049\/jimmunol.168.1.466","article-title":"Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T\/null-cell lymphoma","volume":"168","author":"Zhang","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0165","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1073\/pnas.93.17.9148","article-title":"Activation of Jak\/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome","volume":"93","author":"Zhang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0170","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1172\/JCI119869","article-title":"B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues","volume":"100","author":"Frank","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0175","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1182\/blood-2009-10-230060","article-title":"STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells","volume":"115","author":"Hazan-Halevy","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0180","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/sj.leu.2403667","article-title":"VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance","volume":"19","author":"Lee","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0185","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0190","first-page":"77","article-title":"Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g","volume":"97","author":"B\u00f6yum","year":"1968","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcmd.2013.01.011","article-title":"Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia","volume":"51","author":"Antosz","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0200","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/jcp.39.7.713","article-title":"Autoimmunity in chronic lymphocytic leukaemia","volume":"39","author":"Hamblin","year":"1986","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0205","first-page":"593","article-title":"Different expression of CD180, CD284 and CD14 receptors on the CD19+ subpopulation of normal and B-CLL lymphocytes","volume":"47","author":"Antosz","year":"2009","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bcmd.2012.03.006","article-title":"TLR2 may influence the behavior of the malignant clone in B-CLL","volume":"49","author":"Antosz","year":"2012","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0215","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1182\/blood-2002-12-3647","article-title":"Map kinase signaling pathways and hematologic malignancies","volume":"101","author":"Platanias","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0220","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.exphem.2006.05.019","article-title":"Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation","volume":"34","author":"Hartman","year":"2006","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0225","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.pas.0000213338.25111.d3","article-title":"Bonemarrow phospho-STAT5 expression in non-CML chronic myeloproliferative disorders correlates with JAK2 V617F mutation and provides evidence of in vivo JAK2 activation","volume":"31","author":"Aboudola","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0230","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1517\/14728222.8.5.409","article-title":"STAT proteins as novel targets for cancer drug discovery","volume":"8","author":"Turkson","year":"2004","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0235","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1038\/sj.onc.1203925","article-title":"Janus kinases: components of multiple signaling pathways","volume":"19","author":"Rane","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0240","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1182\/blood.V100.9.3068","article-title":"The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis","volume":"100","author":"Mark","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0245","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-4598-9-309","article-title":"Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells","volume":"9","author":"Huang","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0250","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/cncr.22999","article-title":"Interleukin-6 and its receptor in cancer: implications for translational therapeutics","volume":"110","author":"Hong","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0255","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/cncr.10772","article-title":"Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia","volume":"95","author":"Lai","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0260","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood-2008-02-140673","article-title":"Toll-like receptors: lessons to learn from normal and malignant human B cells","volume":"112","author":"Chiron","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0265","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1073\/pnas.0812579106","article-title":"CD5 sweetens lymphocyte responses","volume":"106","author":"Lenz","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0270","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1182\/blood-2002-05-1525","article-title":"Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production","volume":"100","author":"Gary-Gouy","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0275","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.4049\/jimmunol.1003050","article-title":"CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation","volume":"186","author":"Garaud","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcmd.2014.11.006_bb0280","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)00116-1","article-title":"Signal transduction by the JNK group of MAP kinases","volume":"103","author":"Davis","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2014.11.006_bb0285","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1038\/onc.2012.448","article-title":"Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma","volume":"32","author":"Barbarulo","year":"2013","journal-title":"Oncogene"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614001399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614001399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:31:06Z","timestamp":1761049866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979614001399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1079979614001399"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.11.006","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-6, IL-10, c-Jun and STAT3 expression in B-CLL","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}